Bhubaneswar: Breast cancer has ranked number one cancer among Indian females with age adjusted rate as high as 25.8 per 100,000 women and mortality 12.7 per 100,000 women. Mortality-to-incidence ratio was found to be as high as 66 in rural registries whereas as low as eight in urban registries. There are multiple reasons for late detection including lack of awareness, shyness on part of patients, social stigma, and ignorance at primary and secondary health care level. Early detection is the best choice for reducing mortality.
Nearly 54% of Indian patients have advanced disease and 30% have aggressive breast cancer subtype of Triple Negative Breast Cancer (TNBC) compared to 12% observed in the US. These factors further increase the challenge of managing breast cancer in India and have been major factors potentially related to high mortality observed in Indian breast cancer patients. Currently, the 5-year survival of breast cancer patients is 66% in India, which is lower than the global average. Within BRICS nations, this survival rate is second lowest slightly higher than in South Africa. In India, the burden of breast cancer is increasing due to various factors and more young women reported diagnosed at an advanced stage. Early diagnosis and treating identified patients with appropriate medical management improves the treatment outcome and quality of life and decrease the burden for the patient and the dependent. Current innovative treatment options offer to extend the life of advanced breast cancer patients with an acceptable quality of life.
Odisha Regional Round Table meeting on Breast Cancer was organised by Confederation of Indian Industry (CII) Bhubaneswar Chapter today at Hotel Hindustan International Bhubaneswar in association with Novartis and Government of Odisha Health department.
Naba Kishore Das, Hon’ble Minister of Health and Family Welfare, Govt of Odisha inaugurated the Round Table in presence of Mr. Pradipta Mohanty, Vice Chairman, CII, Odisha State Council, Mr. Prabhat Kumar Sinha, Head Patient Advocacy, Policy and Communication Novartis, Dr Satya Agarwal, Engagement Manager IQVIA, Dr Dinesh Pendharkar, Sr. Oncologist, Advisor to Department Health and Family Welfare, Govt. of Odisha, Dr R R Satpathy, NCD Director/ Dy. Director/ HOD Community Medicine/ ESI/ Railways, Dr Anuj Tiwari, Unit Head AMRI Hospital, Bhubaneswar.